Related Experiment Video

Updated: Aug 7, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Community-acquired PVL+ MRSA in Ireland: a preliminary report

Angela Rossney1, Pamela Morgan, Brian O'Connell

  • 1National MRSA Reference Laboratory, Dublin, Ireland. arossney@stjames.ie

Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|June 13, 2006
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Related Experiment Videos

Last Updated: Aug 7, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...

Articles linked to this work by shared authors, journal, and citation graph.

Impact of ketamine infusions on healthcare utilization and chronic pain: a comparative effectiveness study with insights from real-world data.

Regional anesthesia and pain medicine·2026

Longitudinal Analysis of Fluoride Levels in Irish Water Supplies: A 52-Year Review.

Community dentistry and oral epidemiology·2026

Explainable AI for infection prevention and control: modeling CPE acquisition and patient outcomes in an Irish hospital with transformers.

BMC medical informatics and decision making·2025

The Graduating European Dentist Curriculum Framework: A Multi-Stakeholder View.

European journal of dental education : official journal of the Association for Dental Education in Europe·2025

The World Health Organisation's Global Strategy and Action Plan on Oral Health: A Collaborative Response From Oral Health Professionals' Education Associations.

European journal of dental education : official journal of the Association for Dental Education in Europe·2025

Deficits in temporal pain inhibition are associated with greater pain and functional impairment in osteoarthritis.

Pain·2025

Analysis of minimum inhibitory concentrations of azithromycin, ceftriaxone and ciprofloxacin for Neisseria gonorrhoeae from antimicrobial resistance sentinel surveillance, Germany, 2014 to 2023.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026

Mapping nationally adopted targets for antimicrobial consumption and stewardship indicators in the human health domain, 25 European Union/European Economic Area countries, 2025.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026

Detection of a novel Shamonda Orthobunyavirus in dairy cattle, France, June 2026.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026

Strengthening mosquito control to manage emerging mosquito-borne diseases.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026

Antibiotic treatment and antimicrobial resistance in urinary tract infections among the older population in Denmark, 1999 to 2023.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026

Multi-country study on the impact of a revised consensus definition of late HIV diagnosis, Europe, 2022 to 2023.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us